Multiparametric Ultrasound in the Diagnosis of Hepatocellular Carcinoma in Patients without Cirrhosis (Clinical Case)

Purpose: To demonstrate the capabilities of a complex of multiparametric ultrasound and MRI with intravenous contrast in the detection and characterization of atypical hepatocellular carcinoma with the example of a clinical case of a middle-aged patient without liver cirrhosis.

Material and methods: Comprehensive study of medical history, outpatient records, results of clinical, laboratory, instrumental and morphological methods with independent retrospective analysis of the histological preparation of focal liver lesion.

Results: Diagnostic search data are presented in a 48-year-old patient with hepatocellular carcinoma without signs of liver cirrhosis. The diagnosis required 1.5 months of examination in gastroenterological department, repeated review of the histological preparation by morphologists. The disease debuted with weakness after physical exertion, which was noted during a planned multiparameter abdomen ultrasound examination. During the study, multiple focal formations with uneven fuzzy contours, an inhomogeneous structure were visualized. Stiffness of the parenchyma in focal liver lesion is 108.29 kPa due to 2D-SWE. Further tactics consisted of hospitalization with further laboratory examination and abdomen MRI with intravenous contrast enhancement. Considering the results of instrumental examination, the patient was prescribed a puncture aspiration biopsy of focal liver lesion under ultrasound control followed by morphological verification.

Conclusion: The presented clinical observation demonstrates the need of use an integrated approach in instrumental imaging methods in the diagnosis of atypical hepatocellular carcinoma.

1. Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-73. DOI: 10.1053/j. gastro.2011.12.061.

2. Назаренко АВ, Ткачев СИ, Алиева СБ и др. Современные методики дистанционной лучевой терапии в лечении больных гепатоцеллюлярным раком. Медицинский алфавит. 2019;1(10):29-34. [Nazarenko AV, Tkachyov SI, Alieva SB, et al. Modern methods of external-beam radiation therapy in treatment of patients with hepatocellular carcinoma. Medical Alphabet. 2019;1(10):29-34. (In Russ.)]. DOI: 10.33667/2078-5631-2019-1-10(385)-29-34.

3. Вosh FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-85.

4. Beasley RP, Hwang LY, Overview on the epidemiology of hepatocellular carcinoma. In: Hollinger FB, Lemon SM, Margolis HS. 5. Viral Hepatitis and Liver Disease. Baltimore: Williams SI, Wilkins, 1991:532-5.

5. Huo TI, Lee SD, Wu JC. For hepatocellular carcinoma: look for a perfect classification system. J Hepatol. 2004;40(6):1041-2.

6. Soper R, Himmelreich U, Painter D, et al. Pathology of hepatocellular carcinoma and precursors using proton resonance spectroscopy and statiatical classification strategy. Pathology. 2007;34(5):417-22.

7. Jeong S, Aviata H, Katamura Y, et al. Lowdose intermittent interferon — alpha therapy for HCV — related liver cirrosis after curative treatment of hepatocellular carcinoma. World J Gastroenterology. 2007;113:5188-95.

8. Barazani Y, Hiatt JR, Tong MJ, et al. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg. 2007;31:1245-50.

9. Акберов РФ, Зогот СР, Ким АБ. Комплексная клинико-лучевая диагностика холангиоцеллюлярного рака. Врач-аспирант. 2011; 5.1(48):121-5. [Akberov RF, Sogot MS, Kim AB. Complex clinical and radiological diagnostics of cholangiocellular cancer. Doctor-Graduate Student. 2011;5.1(48):121-5. (In Russ.)].

10. Труфанов ГЕ. Лучевая диагностика заболеваний печени (МРТ, КТ, УЗИ ОФЭКТ и ПЭТ). Под ред. Г.Е. Труфанова. М.: ГЭОТАР-Медиа, 2008. 263 с. [Trufanov GE. Radiation diagnostics of liver diseases (MRI, CT, ultrasound, SPECT and PET). Ed. by GE Trufanov. Moscow. 2008. 263 p. (In Russ.)].

11. Акберов РФ, Зыятдинов КШ, Зогот СР и др. УЗИ в сочетании с магнитно-резонансной томографией в дифференциальной диагностике злокачественных и доброкачественных очаговых заболеваний печени. Поволжский Онкологический Вестник. 2012;1:15-21. [Akberov RF, Ziatdinov KSh, Sogot CP, et al. Ultrasound in combination with magnetic resonance imaging in the differential diagnosis of malignant and benign focal liver diseases. Povolzhsky Cancer Bulletin. 2012;1:15-21. (In Russ.)].

12. Alba E, Valls C, Domingues J, et al. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. Am J Roentgenol. 2008;190(5):1341-8.

13. Гранов ДА. Трансплантация печени при гепатоцеллюлярном раке. Практическая онкология. 2008;9(4):273-40. [Granov DA. Liver transplantation in hepatocellular cancer. Practical Oncology. 2008;9(4):273-40 (In Russ.)].

14. Базин ИС. Гепатоцеллюлярный рак — современное состояние проблемы. Практическая о кология. 2008;9(4):216-29. [Bazin IS. Hepatocellular cancer — current state of the problem. Practical Oncology. 2008;9(4):216-29 (In Russ.)].

15. Борсуков АВ. Эластография сдвиговой волны в диагностике метастатического поражения печени при проведении мультипараметрического ультразвукового исследования. Колопроктология. 2017;S2(60):26-31. [Borsukov AV, Morozova TG. Shearwave Elastography In The Liver Metastase Diagnosis During Multiparametric Ultrasound. Coloproctology. 2017;S2(60):26-31 (In Russ.)].

16. Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014 Oct; 273(1):30-50. DOI: 10.1148/radiol.14132362

17. Bleeker JS, Quevedo JF, Folpe AL. ‘Malignant’ perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma. 2012;2012.